Modulation of cholinergic dysfunction, oxidative stress, and neuroinflammation by selected phytochemicals: neuroprotective evidence from in vitro biochemical and cell-based models of Alzheimer’s disease
Abstract
Alzheimer’s disease is a progressive neurodegenerative disorder associated with cholinergic dysfunction, oxidative stress, neuronal damage, and neuroinflammation. Flavonoids possess multitarget therapeutic potential owing to their antioxidant and anti-inflammatory activities, which contribute to their neuroprotective effects. The present study evaluated the neuroprotective potential of genistin (GIN) and epicatechin gallate (ECG) by assessing their antioxidant, anti-cholinesterase, and anti-inflammatory activities using biochemical and cell-based models relevant to Alzheimer’s disease. Anti-cholinesterase activity was assessed through acetylcholinesterase and butyrylcholinesterase inhibition assays, whereas antioxidant capacity was evaluated using DPPH, ABTS, ferric reducing antioxidant power, superoxide dismutase-like, and catalase assays. Neuroprotective activity was investigated in amyloid-beta (Aβ)-induced SH-SY5Y cells through morphological evaluation, MTT-based cell viability, and malondialdehyde estimation. Anti-inflammatory activity was assessed in LPS-stimulated BV-2 microglial cells using cell viability and nitric oxide inhibition assays. Both GIN and ECG exhibited concentration-dependent cholinesterase inhibition and significant antioxidant activity. ECG (IC 50 = 12.85 ± 0.75 µM) exhibited stronger AChE inhibitory activity than GIN (IC 50 = 17.13 ± 0.79 µM). In SH-SY5Y cells, Aβ exposure markedly reduced cell viability, induced morphological damage and lipid peroxidation, whereas treatment with GIN and ECG improved cellular viability, preserved neuronal morphology, and attenuated oxidative stress, with ECG showing greater protective effects (97.67% ± 5.1% cell viability at 10 μM; 1.78 ± 0.07 nmol/mg of MDA levels). In BV-2 microglial cells, both compounds-maintained cell viability above 95% and significantly suppressed LPS-induced NO production in a concentration-dependent manner. Across multiple experimental models, ECG exhibited comparatively stronger activity than GIN. Overall, the findings demonstrate that GIN and ECG exhibit cholinesterase inhibitory, antioxidant, neuroprotective, and NO-inhibitory activities using biochemical assays and in vitro cell models. The results support their potential as promising experimental candidates for further investigation in Alzheimer’s disease.